Rare diseases
Investigational molecules
Locations
Back to Poland31 clinical trials in Nowy Targ, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PolandStudy on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers
PolandStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
PolandPhase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
PolandStudy of icotrokinra for adults with moderately to severely active Crohn's disease
PolandTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on ulcerative colitis and Crohn's disease treatments, evaluating novel therapeutic agents including obefazimod, rosnilimab, and TEV-48574 for patients with moderate to severe conditions.
These studies aim to improve treatment options for patients who haven't responded well to conventional therapies.
Groundbreaking research investigating treatments for atherosclerotic cardiovascular disease and acute coronary syndrome, including studies on inclisiran and antiplatelet strategies.
These trials focus on reducing major adverse cardiovascular events and improving patient outcomes.
Innovative research examining treatments for gastroparesis and psoriatic arthritis, testing medications like naronapride and deucravacitinib.
These studies aim to address both digestive system disorders and inflammatory joint conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
